Adam Snook, PhD
Associate Professor
![Adam Snook, PhD](/content/academic/academics/colleges-schools-institutes/skmc/departments/pharmacology/faculty-staff/faculty/snook/_jcr_content/profile/image.img.jpg)
Contact
Featured Links
Adam Snook, PhD
Associate Professor
Education
PhD, Immunology and Microbial Pathogenesis, Thomas Jefferson University (2008)
BS, Pharmacology and Toxicology, University of the Sciences (2001)
Publications
- GUCY2C signaling limits dopaminergic neuron vulnerability to toxic insults
- Biomarkers for Managing Neurodegenerative Diseases
- In vitro assays to evaluate CAR-T cell cytotoxicity
- Dietary L-Tryptophan consumption determines the number of colonic regulatory T cells and susceptibility to colitis via GPR15
- IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanism
Expertise & Research Interests
My research has focused on the discovery and clinical development of novel cancer immunotherapeutics targeting the self/tumor antigen guanylyl cyclase C (GUCY2C; GCC). Please refer to my laboratory site for current research.